SecBot SecBot

HSIC

HENRY SCHEIN INC
Nasdaq· Wholesale-Medical, Dental & Hospital Equipment & Supplies· Inc. DE· CIK 0001000228 Healthcare & Medical Devices
$84.96 −1.26 (−1.46%)
Nov 16 4:00 PM ET · prev $86.22
Market cap
$9.5B
Mid cap
Consensus
Buy
58% Buy or better · 24 analysts
Median target
$100.00
+18% · range $64.00–110.00
1 year
+19.2%
from $71.25 · Nov 17
30 days
+1.2%
from $83.97
52-week range
$68.99–90.86
−6% from high · low May 11
Avg volume 20D
1.66M
Nov 3 spike 4.42M
Short interest
9.36M
≈8.5% of shares · +4.0%
Days to cover
8.3
at average volume
Insider net
−$338.6K
1 buyer · 4 sellers · since Mar 4
New fund stakes
4
Q2 2026 13F · 0 exits
Filing reports
24
analyzed by SecBot
SecBot read MIXED 6 reports · 90 days
Balance 1 bearish · 1 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersMIXED

    1 insider bought $691.9K at an average $69.19. 4 insiders sold $1.0M. Price is 23% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 41 added (4 new), 24 trimmed or exited. Largest new: Balyasny Asset Management $19.4M, Woodline Partners $15.6M.

  • AnalystsBULLISH

    14 of 24 rate it Buy or better. Median target $100.00 (+18%).

  • Short sellersSTEADY

    Short interest +4.0% to 9.36M shares. 8.3 days to cover, ≈8.5% of shares.

  • TrendRANGE

    1% below its 50-day average.

Who's buying

13F· Q2 2026
4
new positions
0
exits
$56.4M
in new stakes
FundMoveSharesValue
FMR LLCADD7,553,901$630.9M
CITADEL ADVISORS LLCDOUBLED2,921,103$244.0M
MORGAN STANLEYADD2,100,819$175.5M
UBS Group AGADD1,336,843$111.7M
GOLDMAN SACHS GROUP INCADD1,174,216$98.1M
NOMURA HOLDINGS INCDOUBLED922,721$77.1M
Nuveen, LLCADD458,119$38.3M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED430,686$36.0M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

24 analysts
Buy 58% rate it Buy or better
Strong Buy6Buy8Hold9Sell1Strong Sell0
12-month targets · 15 analysts

Price is inside the target range. Median implies +18%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 4, 2026UBS
MAINTAIN
MAINTAINNeutral
Nov 4, 2026Evercore ISI Group
MAINTAIN
MAINTAINOutperform
Oct 14, 2026Leerink Partners
MAINTAIN
MAINTAINMarket Perform
Aug 19, 2026BTIG
MAINTAIN
MAINTAINBuy
Aug 6, 2026Barclays
MAINTAIN
MAINTAINOverweight
Aug 5, 2026UBS
MAINTAIN
MAINTAINNeutral

Washington

Corporate Lobbying

16 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$691.9K
bought · 1 insider
$1.0M
sold · 4 insiders
+22.8%
vs their $69.19 cost
DateInsiderTypeValue
Sep 8, 2026
Albertini Andrea
CEO, Global Dist. & Tech.
Sep 8, 2026
TAX W/H$53.6K
Sep 8, 2026
Albertini Andrea
CEO, Global Dist. & Tech.
Sep 8, 2026
TO ISSUER3,984 sh
Jun 12, 2026
DANIEL WILLIAM K
Director
Jun 12, 2026
AWARD2,215 sh
May 26, 2026
BERGMAN STANLEY M
May 26, 2026
GIFT50 sh
May 21, 2026
BERGMAN STANLEY M
Director
May 21, 2026
GIFT50 sh
May 19, 2026
BERGMAN STANLEY M
Director
May 19, 2026
GIFT1,040 sh
May 11, 2026
DANIEL WILLIAM K
Director
May 11, 2026
BUY$691.9K
Mar 19, 2026
Popeck Thomas C
CEO, Henry Schein Products
Mar 19, 2026
SELL$98.6K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
HSIC trades disclosed by members of Congress, with disclosure delay.
2 members · 0 buys / 2 sells
DateMemberType AmountDisclosed
May 15, 2026 Ro KhannaDHouse Spouse account · HENRY SCHEIN Inc SELL $1K–$15K Jun 9, 2026 +25d
Jan 9, 2026 Michael McCaulRHouse Spouse account · HENRY SCHEIN Inc SELL $15K–$50K Feb 11, 2026 +33d

Short side

FINRA· Oct 30, 2026
9,361,402
shares short
+4.0%
vs prior settlement
8.3
days to cover
≈8.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 12, 2026 SEC
Artisan Partners Limited Partnership filed an amended Schedule 13G disclosing a 4.8% passive stake in Henry Schein as…
SC 13G/A · Impact 4/10
Nov 6, 2026 SEC
Emmanuel Caprais filed a Form 3 initial statement of beneficial ownership with the SEC, reporting no securities…
3 · Impact 1/10
Nov 6, 2026 Event
PHYTONADIONE
BOXED WARNING WARNING, INTRAVENOUS AND INTRAMUSCULAR USE Severe reactions, including fatalities, hav
Nov 3, 2026 Earnings result
HSIC Q3 2026 Earnings: EPS $1.56 (+12.6% vs est)
Sep 8, 2026 Insider
Albertini Andrea surrendered for taxes 603 shares
CEO, Global Dist. & Tech. @ $88.86 ($53.6K)
Sep 8, 2026 Insider
Albertini Andrea disposed of 3,984 shares
CEO, Global Dist. & Tech.
Jun 30, 2026 Inst.
FMR LLC · ADD
7,553,901 shares ($630.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

24 filings · 2 bullish · 4 bearish · 2 mixed · 16 neutral
All HSIC filing & press-release reports (24)